New drug combo challenges standard treatment in advanced colon cancer trial
Disease control
Recruiting now
This study is testing whether a new combination of two drugs (DSP107 and atezolizumab) works better and is safer than an existing treatment (fruquintinib) for people with advanced colorectal cancer that has stopped responding to standard therapies. About 90 participants will be r…
Phase: PHASE2 • Sponsor: Kahr Bio Australia Pty Ltd • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC